A study released on Monday shows that women using two popular hormonal contraceptives put themselves – and their partners – at greater risk for HIV. While this is a problem for all users of these drugs, it is particularly worrying to people in southern and eastern Africa, where these affordable and easily available contraceptives are used in a very high risk environment. Pam Belluck, science journalist for The New York Times, and Dr. Helene Gayle, president and CEO of CARE, a humanitarian organization with programs to end poverty in nearly 70 countries, talk about the details of the study and what can be done to prevent HIV in Africa.
The story you just read is accessible and free to all because our listener community contributes to our nonprofit newsroom. We go deep to bring you the human-centered international reporting that you know you can trust. To do this work and to do it well, we rely on the support of our listeners. If you appreciate our coverage, if there has been a story that made you pause or a song that moved you, would you consider making a gift to sustain our work? All donations between now and June 30 will be matched 2:1, tripling your impact.